Table 1.
Study | Cohort size | Whites | Blacks | Hispanics | Asians |
---|---|---|---|---|---|
Acute lymphoblastic leukemia | |||||
SEER database 5-year overall survival8 |
4,952 | 84% | 75% | 72% | 81% |
Cooperative group 5-year EFS9 |
8,447 | 72.8%±0.6% | 61.5%±2.2% | 65.9%±1.5% | 75.1%±3.5% |
Cooperative group 5-year overall survival10 |
5,086 | 81.9% 0.6% | 68.6% 2.1% | 74.9% 2% | – |
Single institution 5-year EFS11 |
412 | 79.4% (74.7-84.1) | 80.7% (70.3-91.1) | — | — |
Acute myeloid leukemia | |||||
Cooperative group 5-year overall survival15 |
791 | 48%±4% | 34%±10% | 37%±9% | – |
Cooperative group 5-year overall survival15 |
850 | 60%±4% | 45%±12% | 51%±8% | — |
Single institution 5-year EFS16 |
287 | 31.2%± 3.5% | 29.3%±6.4% | — | — |
Hodgkin lymphoma | |||||
Single institution 5-year EFS18 |
327 | 84%±2.4% | 71%±6.1% | — | — |
Rhabdomyosarcoma | |||||
Cooperative group 5-year EFS19 |
2057 | 66% | 61% | ||
Neuroblastoma | |||||
Cooperative group 5-year EFS26 |
3,539 | 67% (65%-69%) | 56% (50%-625) | 69% (63%-74%) | 62% (51%-71%) |